Long-term outcome of individualized prophylactic treatment of children with severe haemophilia

British Journal of Haematology

Volumn 112, Issue 3, 2001, Pages 561-565

  Van Den Berg, H M ^a,b   Fischer, K ^a,b   Mauser Bunschoten, E P ^a   Beek, F J A ^b   Roosendaal, G ^a   Van Der Bom, J G ^a,b   Nieuwenhuis, H K ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Arthropathy; Prophylaxis; Severe haemophilia

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ADOLESCENT; ADULT; ARTHROPATHY; ARTICLE; BLEEDING; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; FEMALE; HEMOPHILIA; HUMAN; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; SCORING SYSTEM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FACTOR VIII; FOLLOW-UP STUDIES; HEMOPHILIA A; HEMOPHILIA B; HEMORRHAGE; HUMANS; JOINT DISEASES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035106558     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02580.x     Document Type: Article

References (23)

1. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs
2. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized
3. Cost-effectiveness - Can it be measured?
4. Prophylactic use of factor VIII: An economic evaluation
5. Long-term therapy and on-demand treatment of children and adolescents with severe haemaophilia A: 12 years of experience
6. Pharmacokinetic dosing in prophylactic treatment of haemophilia A
7. Repoducibility of the Pettersson scoring system. An interobserver study
8. Radiological and orthopedic score in pediatric hemophilic patients with early and late prophylaxis
9. Prophylaxis: Musculoskeletai evaluation
10. Haemophfiia prophylaxis in young patients - A long-term follow-up
11. Results of secondary prophylaxis in children with severe hemophfiia
12. Management of haemophilia in Sweden
13. Experience with prophylaxis in Sweden
14. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B
15. Our experience in Sweden with prophylaxis in haemophilia
16. Utility of magnetic resonance imaging for management of hemophilic arthropathy in children
17. Types of bleeding seen during the first 30 months of life in childen with severe haemophilia A and B
18. Prophylaxis with factor concentrates in preventing hemophilic arthropathy
19. Radiologic evaluation of prophylaxis in severe haemophilia
20. The frequency of joint bleedings in early childhood in patients with severe haemophilia
21. Experience with prophylaxis in Germany
22. Episodic versus prophylactic infusions for hemophilia A: A cost-effectiveness analysis
23. Prophylaxis of joint hemorrhages in hemophilia